MIRM vs STT · rev $336.1M vs P/E 17, rev $7.84B
Mirum Pharmaceuticals Inc (MIRM) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
State Street Corp (STT) is a asset management company listed on US.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
MIRM currently screens at market cap $6.22B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the MIRM and STT stock pages for the full models.
Not investment advice.